Table 3.
Complete Response Rate for Classified Variables (n=141)
| Complete Response (CR) | |||||
|---|---|---|---|---|---|
| Variables | No | Yes | CR rate | p | |
| Age | <65 | 51 | 62 | 0.78 | 0.368 |
| ≥65 | 10 | 18 | 0.23 | ||
| Gender | Male | 58 | 75 | 0.94 | 0.999 |
| Female | 3 | 5 | 0.06 | ||
| Tumor subsite | Hypopharynx | 39 | 44 | 0.55 | 0.285 |
| Larynx | 22 | 36 | 0.45 | ||
| Induction chemotherapy with Taxotere | No | 36 | 51 | 0.64 | 0.567 |
| Yes | 25 | 29 | 0.36 | ||
| TNM stage | I/II/III/IVA | 24 | 55 | 0.69 | <0.001 |
| IVB | 37 | 25 | 0.31 | ||
| T classification | T1/2 | 10 | 32 | 0.40 | 0.002 |
| T3/4a/b | 51 | 48 | 0.60 | ||
| N classification | N0/1/2/3a | 29 | 60 | 0.75 | 0.001 |
| N3b | 32 | 20 | 0.25 | ||
| Tumor subsite | Larynx Hypopharynx |
22 39 |
36 44 |
0.62 0.53 |
0.285 |
| SIRI | <3.26 ≥3.26 |
40 21 |
72 8 |
0.9 0.1 |
<0.001 |
| LMR | ≤2.99 | 33 | 25 | 0.31 | 0.006 |
| >2.99 | 28 | 55 | 0.69 | ||
| NLR | <2.95 | 30 | 43 | 0.54 | 0.591 |
| ≥2.95 | 31 | 37 | 0.46 | ||
Abbreviations: SIRI, systemic inflammation response index; NLR, neutrophil–lymphocyte ratio; LMR, lymphocyte–monocyte ratio.